Učitavanje...
Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
Treatment of type 1 diabetes (T1D) is currently based exclusively on insulin replacement therapy. However, there is a need for better glycemic control, lower hypoglycemia rates, more effective weight management, and further reduction of cardiovascular risk in people with T1D. In this context, agents...
Spremljeno u:
| Izdano u: | World J Diabetes |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475707/ https://ncbi.nlm.nih.gov/pubmed/31040899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v10.i4.234 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|